Tongue cancer Treatment in Uni-asia Cancer hospital

Uni-Asia Cancer Hospital in Chengdu, China, provides specialized care for tongue cancer using advanced minimally invasive methods. Patients can start their journey with an online oncologist consultation for around $150, while imaging such as a PET/CT scan typically costs $1,300. The hospital is known for its multidisciplinary team approach, led by experts like Prof. Liao Zhengyin, who has over 30 years of experience in interventional oncology.

Advanced diagnostics for tongue cancer

The diagnostic process focuses on determining the exact stage and location of the tumor. Accurate imaging helps the medical team plan the most effective treatment route. The clinic offers the following services:

• Online consultation with oncologist. This allows patients to discuss their case and review medical records before traveling, costing around $150.
• CT scan of the whole body. This imaging helps detect if the cancer has spread to other areas and costs around $1,300.
• PET/CT. A high-resolution scan used for precise tumor localization and staging, priced around $1,300.

Minimally invasive and surgical treatments

The clinic specializes in techniques that protect healthy tissue and preserve tongue function. Doctors choose the method based on whether the lesion is new or recurrent. Options at the facility include:

• Surgical resection. This is the primary choice for early-stage cancer. It includes a sentinel lymph node biopsy and microsurgical reconstruction to restore the tongue's appearance and function.
• Laser ablation. This method treats superficial lesions. It causes minimal damage to the surrounding healthy tissue.
• Photodynamic therapy. This technique uses a light-sensitive drug and specific light activation to target superficial tumors.
• Radiofrequency and microwave ablation. These image-guided procedures are used to control recurrent lesions locally.
• Chemoradiotherapy. This combined approach is for patients with locally advanced cancer or those at high risk of recurrence.
• Immunotherapy. The clinic uses immune checkpoint inhibitors to trigger a durable response against oral cancer cells.

Expertise of Prof. Liao Zhengyin

Prof. Liao Zhengyin leads the interventional oncology department. He is a former Senior Visiting Scholar at Johns Hopkins Hospital. With over 30 years of experience, Prof. Liao Zhengyin has performed 40,000+ procedures. He is recognized in China as a leading figure in multidisciplinary teams for complex tumors.

If you or a loved one needs a consultation for tongue cancer, you can leave a request on Bookimed to receive a personalized treatment plan.